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Abstract
Background: We and others have recently demonstrated that the human retrovirus HTLV-I was
producing a spliced antisense transcript, which led to the synthesis of the HBZ protein. The
objective of the present study was to demonstrate the existence of antisense transcription in HIV-
1 and to provide a better characterization of the transcript and its regulation.
Results: Initial experiments conducted by standard RT-PCR analysis in latently infected J1.1 cell
line and pNL4.3-transfected 293T cells confirmed the existence of antisense transcription in HIV-
1. A more adapted RT-PCR protocol with limited RT-PCR artefacts also led to a successful
detection of antisense transcripts in several infected cell lines. RACE analyses demonstrated the
existence of several transcription initiation sites mapping near the 5' border of the 3'LTR (in the
antisense strand). Interestingly, a new polyA signal was identified on the antisense strand and
harboured the polyA signal consensus sequence. Transfection experiments in 293T and Jurkat cells
with an antisense luciferase-expressing NL4.3 proviral DNA showed luciferase reporter gene
expression, which was further induced by various T-cell activators. In addition, the viral Tat protein
was found to be a positive modulator of antisense transcription by transient and stable
transfections of this proviral DNA construct. RT-PCR analyses in 293T cells stably transfected with
a pNL4.3-derived construct further confirmed these results. Infection of 293T, Jurkat, SupT1, U937
and CEMT4 cells with pseudotyped virions produced from the antisense luciferase-expressing
NL4.3 DNA clone led to the production of an AZT-sensitive luciferase signal, which was however
less pronounced than the signal from NL4.3Luc-infected cells.
Conclusion: These results demonstrate for the first time that antisense transcription exists in
HIV-1 in the context of infection. Possible translation of the predicted antisense ORF in this
transcript should thus be re-examined.
Published: 2 October 2007
Retrovirology 2007, 4:71 doi:10.1186/1742-4690-4-71
Received: 22 June 2007
Accepted: 2 October 2007
This article is available from: http://www.retrovirology.com/content/4/1/71
© 2007 Landry et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 16
(page number not for citation purposes)
Retrovirology 2007, 4:71 http://www.retrovirology.com/content/4/1/71Background
It has been largely accepted that gene expression in retro-
viruses solely relies on a single transcript, which is in turn
either left unspliced, singly or multiply spliced. This tran-
script is initiated from the 5' LTR region, which harbours
in its U3 segment most of the necessary binding sites for
important transcription factors regulating the expression
of retroviral genes. In addition, for all studied retroviruses,
this transcript initiates at a single position and is typically
dependent on an upstream TATA box. Few studies have
addressed the possible existence of transcripts initiated at
other position in the retroviral genome. A number of
reports have however provided an interesting and unex-
pected possibility to retroviral gene expression. Indeed, in
a few complex retroviruses including HIV-1, FIV-1 and
HTLV-I, it has been suggested that transcripts produced in
the antisense direction exist and that these transcripts
could have the potential to encode for a protein [1-4].
Although these results have been debated and largely con-
tested, new results obtained with the HTLV-I virus have
importantly revived the issue over antisense transcription
[2,5-15]. Indeed, the HTLV-I retrovirus has been the first
retrovirus from which the existence of an antisense tran-
script has been clearly demonstrated. Recent studies have
further highlighted the spliced nature of this transcript
[12-14]. The HBZ protein encoded from this transcript
was shown to have AP-1 and Tax inhibitory activity and to
be detected in infected cell lines as well as PBMCs from
HTLV-I infected individuals.
The existence of antisense transcription in HIV-1 has been
similarly suggested based on the identification of a con-
served ORF in the antisense strand of its genome. Hence
an initial study by Miller had identified a well conserved
ORF of 189 amino acids, later termed ASP (Antisense Pro-
tein) on the antisense strand, which was generally well
conserved in all analysed HIV-1 proviral DNA [3]. Analy-
sis of the hydrophobic profile of the potentially encoded
protein revealed it to be highly hydrophobic and thus to
possibly be associated to the membrane. Detection of the
ASP protein has only been possible through Western blot
analysis of bacterially produced ASP and electron micros-
copy studies [16]. Despite these studies, no functions have
yet been assigned to this potential virally encoded protein
and its existence remains controversial.
Studies have however been more focussed on the detec-
tion of the antisense transcript itself in HIV-1. The exist-
ence of the transcript has been previously suggested
through Northern blot and RT-PCR approaches [4,17,18].
Studies based on the identification of the 5' and 3' ends of
the antisense transcript have also been performed and
suggested that this transcript was initiating next to the 3'
LTR border, although no consensus was obtained
[4,19,20]. Promoter analyses have been further conducted
by using the isolated 3' LTR positioned in the antisense
orientation and T-cell activators were shown to positively
modulate promoter activity while Tat had an adverse
effect [4,19,21]. Although these analyses have tended to
infer that this pattern of expression was occurring in HIV-
1, numerous artefacts and contradictory results have not
permitted to unequivocally demonstrate that indeed HIV-
1 antisense transcription existed. Therefore reassessment
of antisense expression is directly needed to readdress the
existence of antisense transcription in HIV-1.
In virtue of the recent results on HTLV-I antisense tran-
scription, the goal of this study was to readdress the exist-
ence of antisense transcription in HIV-1. Using an
antisense transcription-specific RT-PCR approach (with
no non-specific RT priming artefact) and an HIV-1 provi-
ral DNA construct expressing the luciferase gene in the
inverse orientation, we provided for the first time strong
evidence demonstrating the presence of HIV-1 antisense
transcripts. Our data also highlight the existence of a new
polyA signal in the antisense strand and strongly support
a positive role for Tat on antisense transcription. These
results add new important information, which will likely
impact on the understanding of HIV-1 replication.
Results
Detection of the antisense transcript in infected and 
transfected cells
Previous studies had earlier suggested that antisense tran-
scription could be detected through RT-PCR analyses [4].
However, in our hands, these protocols were not suitable
for specific detection of antisense transcription as substan-
tial amount of non-specific signals due to endogenous RT
priming was apparent. Endogenous RT priming results
from priming of RNA by small degraded RNA or DNA
fragments present in the extracted RNA pool, which act as
primers during the reverse transcriptase step. Given that
sense expression in retroviruses has been suggested to be
more prominent than antisense transcription, a PCR sig-
nal might thus be overwhelmingly derived from cDNA
produced from sense mRNA primed by degraded DNA/
RNA and not permit to specifically assess the existence of
antisense transcripts. Endogenous RT priming is typically
controlled by conducting PCR amplification of cDNA pro-
duced from RNA in the presence of the reverse tran-
scriptase but in the absence of the RT primer. To detect the
antisense transcript, we chose RT and PCR primers in the
proviral DNA region located in the ASP ORF. As presented
in Figure 1, the ASP ORF is located in the antisense strand
in the env gene. Several primers were designed to provide
signals of different sizes.
Our first RT-PCR analysis was conducted using standard
conditions. However, as indicated above, we expected that
most of endogenous RT priming artefacts in HIV-1-Page 2 of 16
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the sense transcript occurring through the presence of
degraded HIV-1 cellular DNA or antisense RNA. To
decrease this important source of endogenous RT priming
artefact, we first used the J1.1 cell line, which is latently
infected and produces very low amounts of virions when
left unstimulated. RNA extracted from this cell line was
used for cDNA synthesis with an antisense RNA-specific
primer located in the ASP ORF region and PCR was then
conducted with two different sets of ASP ORF-derived
primers. As presented in Figure 2A, specific signals repre-
senting antisense transcription were detected (lanes 6 and
7). The sequencing of these signals confirmed their specif-
icity. Importantly, controls for endogenous RT priming
(absence of primer at the RT step) (lanes 4 and 5) and for
DNA contamination (no RT step) (lanes 1 to 3) were
devoid of any signal further demonstrating that our PCR-
amplified fragments were specific to the antisense tran-
script. Antisense transcription was next tested in 293T
cells transfected with HIV-1 proviral DNA. The NL4.3 pro-
viral was thus chosen and, as argued above, a 5' LTR-
deleted version termed pNL4.3∆NarI was generated to
minimize endogenous RT priming on sense transcripts.
Wild-type and 5' LTR-deleted pNL4.3 constructs were thus
transfected in 293T cells and RT-PCR analyses (as
described above) were undertaken on RNA samples from
these cells (Figure 2B). Again, a specific signal was easily
detected in PCR amplification of cDNA originating from
293T cells transfected with pNL4.3∆NarI (lanes 6 and 7)
and its specificity was further demonstrated by sequenc-
ing. Controls for DNA contamination or endogenous RT
priming indicated no contaminating signals (lanes 1 to
5). As opposed to these results, pNL4.3wt-transfected cells
clearly demonstrated the presence of endogenous RT
priming, which had a comparable intensity to the signal
obtained in the presence of the RT primer (compare lanes
10 and 11 versus 12 and 13 respectively).
We were next interested in demonstrating the presence of
the antisense transcript in chronically infected cells. As we
have demonstrated that sense transcription would likely
be an important source of endogenous RT priming arte-
fact masking the antisense RNA-specific signal, we thus
optimized RT-PCR conditions, which would greatly
diminish non-specific signals (see Methods). Tested
infected cells included OM10.1, ACH-2, J1.1 and U937
HIV-1IIIB (Figure 3 and data not shown). Although the
three first cell lines produces low amounts of infectious
particles, the U937-infected cell line is known to be a
source of substantial levels of produced infectious parti-
cles. The improved RT-PCR protocol consisted of an
extraction of mRNA followed by an RT step with a primer
containing a 3'end complementary to the antisense tran-
script in the ASP region and a non-complementary 5' end.
To remove the RT primer from the reaction, cDNAs are
then purified through the use of a column (DNA cleanup
step). PCR is then performed with a forward primer again
derived from the ASP region and a reverse primer termed
the anchor primer specific to the 5' extremity of the RT
primer. This RT-PCR approach hence strongly favoured
PCR amplification of RT primer-derived cDNAs. Using
this approach, we first tested RNA samples from 293T
Positioning of the ASP antisense ORF in the HIV-I proviral DNAFigure 1
Positioning of the ASP antisense ORF in the HIV-I proviral DNA. The ASP ORF is located on the antisense strand in the region 
of the env gene. Primers used for RT-PCR experiments and the expected sizes of the amplified signals are indicated below the 
enlarged ASP ORF. The arrow indicated the antisense transcript.
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depicted in Figure 3, this approach permitted the detec-
tion of the antisense transcript in both transfected cell
lines using two different primer sets (lanes 5 and 6). In
these experiments, we have also controlled for the specif-
icity of the forward primer used in PCR amplification
(primer 30-20 specific to the non-complementary end of
the 24-6F RT primer) by testing cDNAs produced with
added 24-6 RT primer devoid of the targeted sequence of
this forward primer (lanes 1 and 2). Another crucial con-
trol consisted of ensuring that no 24-6F RT primer
remained in the cDNA reaction after column purification.
Sufficient amount of the RT primer during PCR amplifica-
tion might allow subsequent amplification with the PCR
forward primer 30-20 thereby amplifying any source of
HIV-1 DNA. Hence, purified cDNA prepared from the RT
primer 24-6 was incubated in the presence of an aliquot
of mock prepared cDNA from non-transfected 293T cells
after column purification (lanes 3 and 4). As expected,
none of these controls led to a PCR-amplified signal. With
this approach, we next tested the infected cell lines listed
above. We indeed demonstrate that this protocol allowed
us to specifically detect the antisense transcript in these
infected cell lines (lanes 5 and 6) while no undesirable
contaminating signals were detected (lanes 1 to 4). None
of the RNA samples tested through this protocol had con-
taminating DNA (data not shown).
These results hence demonstrated the existence of an anti-
sense transcript in HIV-1, which included the ASP ORF
sequence. The use of HIV-1 proviral DNA clones and of
infected cell lines suggested that a wide range of HIV-1
strains are capable of producing this transcript.
Identification of multiple transcription initiation sites for 
the HIV-1 antisense transcript
Identification of transcription initiation sites of the anti-
sense transcript of HIV-1 was next undertaken. As an
Specific detection of the antisense transcript in latently infected cells and transfected 293T cells (A) RT-PCR analyses were per-formed on RNA sampl s from J1.1 cell  using the 24-6 RT primer and PCR primer combinations 26-6/26-5 (lanes 1,2,4,6) and 26-6/25-3 (lanes 3,5,7) (expected siz  of 384 bp and 437 bp, resp ctively)Figure 2
Specific detection of the antisense transcript in latently infected cells and transfected 293T cells (A) RT-PCR analyses were per-
formed on RNA samples from J1.1 cells using the 24-6 RT primer and PCR primer combinations 26-6/26-5 (lanes 1,2,4,6) and 
26-6/25-3 (lanes 3,5,7) (expected size of 384 bp and 437 bp, respectively). Samples were tested for DNA contamination (lanes 
2–3; no RT and no RT primer) and endogenous RT priming (lanes 4–5; RT with no added RT primer). Lane 1 represents PCR 
analysis with no added cDNA or RNA. Lanes 6 and 7 show the results of PCR using 2 primers combinations. (B) 293T cells 
were transfected with 5 µg of pNL4.3 or pNL4.3∆Nar1 proviral DNA. RT-PCR analysis of RNA samples from transfected 293 
T cells and controls were performed as in A. M = Lambda EcoRI/HindIII DNA marker (the asterisk indicates the 564 bp band). 
The arrows on the right side of panel A points to the specific signal.Page 4 of 16
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293T cells transfected with pNL4.3∆NarI, these cells were
used as the source of RNA to conduct 5'RACE analyses. In
these analyses, PCR amplification was conducted with
reverse primers positioned near the 5' end of the ASP ORF
region and primers specific to the oligonucleotide ligated
to the 5' end of RNAs (as described in Methods). Migra-
tion of the 5'RACE products initially indicated the pres-
ence of potential multiple transcription initiation sites.
Cloning and sequencing of all amplified products gener-
ated by 5' RACE (Figure 4) indeed confirmed that numer-
ous transcription initiation sites were identifiable for the
HIV-1 antisense transcript and were positioned near the
5'border of the 3' LTR and at more downstream region (in
the antisense strand). The majority of the transcription
initiation sites were located in a 462 bp region encom-
passing the transcription initiation site previously
described by Peeters et al. (1996) [19]. Interestingly, the 3'
part of the 462 bp region (containing the previously iden-
tified CAP site) presented numerous transcription initia-
tion site identified repeatedly by numerous sequenced
PCR amplicons,
These results hence demonstrated that the HIV-1 anti-
sense transcript initiated next to the 3' LTR at multiple
positions (in a region ranging in length from 700 to 1250
bp). This multiplicity of initiation sites might be a conse-
quence of the absence of a TATA box at close distance.
Identification of a new polyA signal in the antisense strand
Previous results had suggested that non-consensus polyA
signals existed at the 3' end of the ASP ORF and were likely
determinant for the polyadenylation of the antisense tran-
script [4]. We next searched for the 3' end of the antisense
transcript by conducting 3'RACE analyses, again using
RNA from pNL4.3∆NarI-transfected 293T cells. Through
this approach, forward primers were initially designed
500 bp upstream of the ASP stop codon in the antisense
strand. However, no signals reminiscent of the presence of
a polyA tail being added to the antisense transcript at
proximity to this region were detected (data not shown).
We thus searched for a potentially new polyA signal and
found an AATAAA consensus sequence at position 4908
of the pNL4.3 molecular clone (sense strand positioning)
in the complementary sequence corresponding to the pol
gene (Figure 5B). Comparison of this polyA consensus
sequence among different HIV-1 strains revealed a high
degree of conservation and further demonstrated its close
localisation to a downstream GT-rich sequence, another
marker for polyA addition [22] (Figure 5C). We thus
repeated our 3' RACE analyses using the RNA sample from
the same transfected 293T cells and used a forward primer
at a distance closer to this potential polyA signal. After
amplification, a specific signal was detected with a size
expected for a polyA tail being present near the polyA sig-
nal (Figure 5A). Cloning and sequencing of the 3'RACE
amplified products further confirmed that the polyA sig-
Specific detection of HIV-1 antisense transcript in infected cells lines and transfected 293T cellsFigure 3
Specific detection of HIV-1 antisense transcript in infected cells lines and transfected 293T cells. Synthesis of cDNA was per-
formed on polyA+ RNA using 24-6 (control RT primer) or 24-6F (floating RT primer) and purified on a PCR-cleanup column. 
PCR amplifications were performed using the reverse primer 30-20 (anchor) and forward primers 26-5 (lane 1, 3, 5) or 25-3 
(lane 2,4 and 6) in order to specifically amplify 24-6F-synthesized cDNA. Samples were tested for anchor primer specificity 
(lanes 1–2) and cDNA cleanup efficiency (lanes 3–4). Lane 5 and 6 show specific amplification of HIV-1 antisense transcript 
from J1.1 OM10.1, U937 and ACH-2 chronically infected cells lines and 293T transfected with complete pNL4.3 proviral DNA 
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19 nucleotide distance) (Figure 5C).
These results hence confirmed that the antisense tran-
script was polyadenylated and a newly identified and well
conserved polyA signal located at 2.4 kb distance from the
ASP stop codon was likely essential for the addition of the
polyA tail.
Modulation of HIV-1 antisense transcription using an 
antisense luciferase-expressing proviral DNA
Our RT-PCR approach represents an important tool in the
detection of a specific signal for antisense transcription.
However, the quantification of changes in antisense tran-
scription levels in the proviral DNA context remained an
essential element. Sense transcription and HIV-1 infection
has been studied by several research groups using proviral
DNA constructs containing the luciferase reporter gene
inserted in the nef gene in frame with its ATG initiation
codon (HXB-Luc and NL4.3LucR-E-) [23,24]. As these
proviral DNA constructs produce virions upon transfec-
tion, we used the pNL4.3LucR-E- construct and removed
its luciferase reporter gene to reinsert this reporter gene in
the same position but in the inverse orientation. The clon-
ing of the luciferase reporter gene in the antisense direc-
tion at this position permitted the usage of the
transcription initiation sites identified above (presented
in Figure 4). This vector, termed pNL4.3AsLucR-E- was
tested in Jurkat and 293T cells and upon transfection, luci-
ferase activity was constantly measured in both cell lines
(293T: 893.7 ± 30 RLU and Jurkat: 2.2 ± 0.3 RLU versus
0.2 RLU as a blank value) (Figure 6A–B).
As previous results had suggested that antisense transcrip-
tion was positively modulated by T-cell activators
[4,19,21], we next tested our antisense luciferase-express-
ing proviral DNA clone for its response to T-cell activators
upon transfection in Jurkat cells (Figure 6B). Our initial
results confirmed previous data in that NF-κB-activating
agents such as PMA and PHA slightly but significantly
induced luciferase activity in transfected Jurkat cells. We
next tested a version of this construct from which the 5'
LTR was deleted to assess if blocking of sense transcription
could impact on the level of induced antisense transcrip-
tion (Figure 6C). This construct termed
pNL4.3∆BstAsLucR-E- was transfected in Jurkat cells,
which were subsequently treated with a wider range of T-
cell activators. Measurement of luciferase activity from
these transfected cells indeed revealed that the 5'LTR-
deleted version was more potent in its response, especially
Identification of transcription initiation sites for the antisense transcriptFigure 4
Identification of transcription initiation sites for the antisense transcript. Total RNA from 293T cells transfected with the 
pNL4∆Nar1 construct was used to amplify 5' cDNA ends using the 5' RACE approach. Numerous transcription initiation sites 
were identified upon sequencing of multiple PCR-amplified signals and are part of a region presented in the enlarged segment 
encompassing the LTR, and both nef and env gene regions. Nucleotide numbering corresponds to the sense strand.
nef 
env U3
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activation.
These results hence demonstrated that quantification of
luciferase activity can be achieved using our
pNL4.3AsLucR-E- construct and that, in the context of this
proviral DNA, we were able to confirm induction of anti-
sense transcription by T-cell activators. Furthermore,
responses toward these T-cell activators seemed to be
modulated by sense transcription.
Upregulation of antisense transcription by the viral Tat 
protein
Previous studies from other groups had hinted on the pos-
sible adversary effect of Tat expression on antisense tran-
scription, although these data might have been artefactual
[4,19,21]. We thus readdressed these findings to provide a
clearer role of Tat on antisense transcription using our
antisense luciferase-expressing NL4.3 clone. As an initial
step, we first looked at Tat modulation on a construct con-
taining a complete LTR cloned upstream and in the
inverse orientation of a luciferase reporter gene. Co-trans-
fection experiments with this construct and a Tat expres-
sion vector (or the empty vector) along with the β-gal
expression vector in the Jurkat cell line were performed
and normalized luciferase activity was subsequently
measured. As demonstrated in Figure 7A, Tat expression
importantly reduced luciferase activity as previously
shown. It is possible that Tat might importantly induce
TAR-dependent sense transcription from the 3'LTR (and
thus in the inverse orientation from the luciferase gene),
which could lead to interference on antisense transcrip-
tion. To evaluate this possibility, the antisense pLTRXLuc
construct was linearized before transfection and then eval-
uated for its Tat response. As shown in Figure 7A, luci-
ferase activity in this construct was now modulated
positively by the viral Tat protein, although linearization
led to an important reduction in basal antisense transcrip-
tion. These results indeed suggested that Tat was rather a
positive modulator of antisense transcription.
Identification of a new functional polyadenylation site for HIV-1 antisense transcriptFigure 5
Identification of a new functional polyadenylation site for HIV-1 antisense transcript. (A) Total RNA from 293T cells trans-
fected with pNL4.3∆NarI was used for 3'RACE analysis. CTL represents PCR amplification conducted in the absence of cDNA 
and RNA samples. The amplified product was cloned and sequenced. M = 100 bp marker (the asterisk indicates the 600 bp 
band). (B) Position of the newly identified antisense polyA addition site (pA indicated with arrow) in the HIV-1 genome. (C) 
Sequence alignment of 8 HIV-1 genome showing conservation for the consensus polyA signal and of a GT-rich consensus 
sequence. Position of the polyA addition site is indicated by an arrow.
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luciferase-expressing proviral DNA. In order to determine
the basal level of antisense transcription in the absence of
Tat protein, we decided to use the 5'LTR-deleted
pNL4.3∆BstAsLucR-E-, which cannot produce Tat. The
luciferase signal from this vector was further compared
between a transfected circular form versus its linear form
following digestion in the gag gene (thereby further elim-
inating possible interference from a full-circle sense tran-
script initiated from the 3'LTR). Upon co-transfection of
pActin-LacZ, pNL4.3∆BstAsLucR-E- and pCMV-tat (or the
empty control vector) in 293T cells, normalized luciferase
activity was determined. In Figure 7B, results of this trans-
fection experiment are presented and indeed argue for a
positive Tat-dependent modulation of antisense transcrip-
tion in the context of the linearized proviral DNA,
whereas a more reduced positive effect of Tat on antisense
transcription was noted with the circular form of the plas-
mid. We then prepared stable 293T cell clones by transfec-
tion of linearized pNL4.3AsLucR-E (similarly digested)
along with pCMV-Hyg and after selection, pooled clones
were co-transfected with pActin-LacZ and pCMV-tat (or
the empty control vector) (Figure 7C). Luciferase read-
outs confirmed that our proviral DNA construct was still
responsive to Tat expression in that Tat could upregulate
luciferase gene expression in the antisense strand in the
chromatin context by more 2.5 folds. When isolated
clones were similarly transfected, all clones responded
positively to Tat expression although at different levels
(Figure 7C). Fold induction were observed to range
between 2 to 17 folds in their response to Tat expression.
We also tested if Tat modulation of antisense transcription
could be demonstrated at the RNA level. We initially
Generation of a proviral DNA construct expressing the antisense directed luciferase gene expressionFigure 6
Generation of a proviral DNA construct expressing the antisense directed luciferase gene expression. (A) 293T cells were 
transfected with 600 ng pNL4.3AsLucR-E- and lysed 48 h post-transfection. CTL represents untransfected cells. (B-C) Jurkat 
cells were transfected with 15 µg pNL4.3AsLucR-E- (B) or pNL4.3∆BstAsLucR-E- (C) and stimulated with different activators 
for 8 h. or left untreated. Lysed cells were then analysed for luciferase activity. Results show the mean luciferase activity values 
of three measured samples ± S.D (A-B) or fold induction compared to the unstimulated control (C).Page 8 of 16
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selected for stable transfectants, from which no HIV-1
sense expression should be detected. The resulting
selected pool was then transfected with pCMV-tat (or the
control vector) and pActin-LacZ. Cells transfected with
comparable efficiency (as determined by β-gal activity)
were then analysed by RT-PCR. In the absence of 5'LTR
and 3'LTR sense transcription, the RT reaction was initially
conducted with random primers (Figure 7D). PCR signals
demonstrated that Tat expression in the context of this
deleted proviral DNA construct was positively affecting
antisense transcription (compare intensities between
lanes 7 and 8). The actin signal was identical in both
transfected cells (lanes 5 and 6) while DNA contamina-
tion controls presented no signals (lanes 1 to 4). To ascer-
tain of the antisense strand specificity of the signal, cDNAs
were also synthesized from this RNA with the 24-6F RT
primer and subsequently analysed for antisense transcrip-
tion using the protocol described in Figure 3 and the com-
bination of two different PCR primer sets. As presented in
panel E, both primer sets indicated an important increase
in the PCR signal attributed to antisense transcription
Modulatory effect of Tat on antisense transcriptionFigure 7
Modulatory effect of Tat on antisense transcription. (A) Jurkat cells were transfected with 10 µg of circular or BamHI-digested 
pAsLTRXLuc plasmid in combination with 5 µg of pCMV-tat or empty pCMV vector. (B) 293T cells were transfected with 400 
ng of circular or BstZ17I-digested pNL4.3∆BstAsLucR-E-, 200 ng of pActin-LacZ and 200 ng of pCMV-tat or empty vector. (C) 
293T cell clones and a pooled population stably transfected with pNL4.3∆BstAsLucR-E- were transfected with 200 ng pCMV-
tat or empty vector. Results are presented as fold induction compared to empty vector. (D) A pool of 293T cells stably trans-
fected for pNL4.3∆Nar1 was transfected with 5 µg of pCMV-tat or the empty pCMV5 vector. cDNA synthesis was performed 
with random primers. PCR amplifications were performed to detect the presence of the HIV antisense transcript (lane 3-4-7-
8) using 24-6/25-3 primers. β-actin amplification was performed as control (lane 1-2-5-6). Lanes 1, 2, 3 and 4 represent control 
for DNA contamination to which RNA was directly added for PCR amplification. (E) RNA from the transfected 293T cells 
described in D were also used for amplification of antisense transcripts from 24-6F-synthesized cDNA using 30-20 (anchor) 
primer in combination with 25-3 (lane 1, 3, 5 and 7) or 26-5 (lanes 2, 4, 6 and 8) primers. Samples were tested for cDNA 
cleanup efficiency (lanes 1, 2, 5 and 6). Tat expression in transfected cells is indicated above the gel for both latter panels. Luci-
ferase activities in A, B and C represent the mean value of three measured samples ± S.D.Page 9 of 16
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4, respectively). The presence of the 24-6F primer in the
PCR reaction was again controlled for in lanes 1–2 and 5–
6, which showed no clear signal indicative of this primer
contamination in the PCR reaction.
The body of results presented above illustrates that the
HIV-1 Tat protein acts positively on antisense transcrip-
tion in the context of a 5'LTR-deleted proviral clone.
Detection of luciferase activity following infection of cells 
by antisense luciferase-expressing virions
Given that the pNL4.3AsLucR-E- vector was constructed
by keeping the structure of the parental vector intact, we
were thus confident that this new vector should allow us
to produce virions, which could be pseudotyped and used
to study antisense transcription during infection. Hence,
pNL4.3AsLucR-E- and the parental pNL4.3LucR-E- were
separately co-transfected with a VSV-G expression vector
in 293T cells. Harvested supernatants indicated that high
levels of p24 capsid proteins were detectable. Subse-
quently, an identical quantity of both pseudotyped viri-
ons (p24 levels) was used to infect 293T cells (Figure 8A–
B). Luciferase activity was detected for both types of viri-
ons above levels measured in non-infected cells (luci-
ferase activity is indicated above each column).
Interestingly, and as expected, luciferase activity was
importantly lower in 293T cells infected with
NL4.3AsLucR-E virions as compared to cells infected with
NL4.3LucR-E- virions. However, it was noted that for both
cell lines, a continuous increase in luciferase activity was
apparent for both viruses between day 1 and 2 and lev-
elled off at day 3. Further experiments using AZT revealed
the specificity of the signal in that pre-treatment of 293T
cells with AZT importantly reduced the luciferase signal
obtained from infection of either virus (Figure 8B). Addi-
tional infection experiments with NL4.3AsLucR-E- virions
were equally conducted in other cell lines, which included
T-cell lines CEMT4, SupT1 and Jurkat and the monocytic
U937 cell line. These infection experiments demonstrated
that, albeit at a lower extent, antisense luciferase reporter
gene expression was detected in all tested cell lines above
levels from uninfected cells, although important differ-
ences with NL4.3LucR-E-infected cells remained (Figure
8C). Jurkat cells infected with NL4.3AsLucR-E- virions
were also tested for several T-cell activators and, as dem-
onstrated through our transfection experiments (Figure
6), induction of luciferase expression by these agents was
demonstrated, being again optimal with the bpV [pic]/
PMA combination (Figures 8D).
These results thus indicated that our antisense luciferase-
encoding proviral DNA can produce virions allowing
quantification of antisense expression by luciferase activ-
ity in several cell types and at different time points post-
infection.
Discussion
Antisense transcription in retroviruses has remained con-
troversial for several years. We and others have recently
demonstrated that this pattern of transcription was exist-
ent in HTLV-I and further experiments have convincingly
shown its coding potential and the important role played
by the HBZ protein [2,5-15]. For HIV-1, antisense tran-
scription has been poorly studied and these studies have
not convinced the HIV-1 research community over the
existence of both antisense transcripts and the ASP protein
[4,16,18,19]. In this study, our goal was to readdress anti-
sense transcription in HIV-1. Our results demonstrate for
this first time that indeed antisense transcription does
exist in HIV-1, likely involves a newly described antisense
polyA consensus sequence and is positively modulated by
T-cell activators and the viral Tat protein. We further
present data on a new proviral DNA construct, which
should allow us to quantify antisense expression in differ-
ent cell types and under different conditions.
We have first set out to detect the antisense transcript in a
specific fashion. Although previous studies had presented
evidence based on RT-PCR analyses supporting its exist-
ence [4,18], endogenous RT priming has been a major
drawback in fully acknowledging the existence of anti-
sense transcription in HIV-1. Our first strategy to avoid
endogenous RT priming was to study antisense transcrip-
tion in the context where sense transcription was greatly
reduced, as these transcripts are likely the major source of
non-specificity masking antisense transcript-specific sig-
nals. J1.1 cells and the pNL4.3∆NarI proviral DNA have
allowed us to achieve this goal and to detect antisense
transcription with a limited presence of endogenous RT
priming. Indeed, an important signal of the expected size
was obtained in both conditions and for pNL4.3, the pres-
ence of the 5'LTR was, as expected, resulting in endog-
enous RT priming. Using a more optimized RT-PCR
approach, we have been successful in detecting an anti-
sense RNA-derived PCR signal in cell lines in which sense
transcription was more active. Our approach uses mRNA
to avoid contaminating DNA (also in small fragments)
and, through the use of a semi-complementary RT primer,
strongly favours amplification of cDNAs synthesized from
this primer and not from contaminating small RNA frag-
ments. Such a comparable approach has been previously
used successfully for the detection of antisense transcrip-
tion in the Hepatitis C Virus [25]. An interesting observa-
tion from our data is that U937-infected cells generated a
strong signal. Whether this is only specific to the cell line
or representative of infected monocytic cells remain to be
determined.Page 10 of 16
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demonstrated that multiple transcription initiation sites
existed for antisense transcripts. It is however worth not-
ing that these initiation sites mainly occur near the 5' bor-
der of the 3' LTR, which differs from what has been
demonstrated for HTLV-I. However, one transcription ini-
tiation site agrees with the results obtained by Peeters et al.
(1996) [19], while our current data do not support results
from other groups including a recent study [4,20]. Proto-
cols and tested cell lines might explain these discrepancies
and further experiments will be needed to confirm our
data on the transcription initiation sites. However, we
have mapped several transcription initiation sites in this
region and have confirmed these data in several experi-
ments using a near full length proviral DNA construct (i.e.
pNL4.3∆NarI).
In our study, unlike HTLV-I antisense transcripts, no
clones from our 5' RACE analyses indicated the presence
of splicing events occurring in the 5' end of the antisense
transcript. In addition, numerous RT-PCR experiments
with primers designed from proviral DNA spanning the
ASP and 3'LTR region have been undertaken and none of
these experiments conducted in 293T cells transfected
with different wild-type or deleted proviral DNA or HIV-1
infected cell lines has permitted to provide evidence for
the existence of splicing at the 5' end of the antisense RNA.
Hence, these results might justify the closer positioning of
Expression of HIV-1 antisense transcript during viral infectionFigure 8
Expression of HIV-1 antisense transcript during viral infection. (A) 293T cells were infected with 35 ng of NL4.3LucR-E- or 
NL4.3AsLucR-E- virions pseudotyped with Vesicular Stomatitis Virus envelope (VSVg) and were lysed at different time points 
post-infection and tested for luciferase activity. In (B), 10 µM or 50 µM of AZT was added to the culture media 1 h before 
infection of 293T cells and luciferase activity was determined after 48 hr. (C) SupT1, Jurkat, CEMT4 and U937 cells were 
infected with NL4.3LucR-E- or VSVg-pseudotyped NL4.3AsLucR-E- virions at a ratio of 1 ng/1 × 105 cells. Cells were lysed 48 
hr post-infection and tested for luciferase activity. (D) Forty-eight hr post-infection, Jurkat cells were seeded at a concentration 
of 1 × 106 cells/ml and stimulated with various cell activators for 8 h. Luciferase activities represent the mean value of three 
measured samples ± S.D. Luciferase activity in panels A, B and C are presented on a logarithmic scale. Mean values of luciferase 
activity are indicated in panels A and C above each column.
D
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codon of the potential ASP ORF (as compared to HTLV-I
HBZ initiation codon) in order to permit sufficient trans-
lation efficiency.
Our characterization of the transcript has also permitted
the identification of a new HIV-1 polyA signal. This signal
is different from the previously suggested polyA signal in
the study of Michael et al. (1994) [4]. However, we have
confirmed the potential usage of our polyA signal by 3'
RACE analysis. In addition, this sequence is conserved
among different strains and obeys to the consensus
sequence. Furthermore, a GT rich sequence is present in
the neighbouring DNA region, again a potent marker for
positioning of polyA tail addition in the transcript. We are
thus confident that this is the polyA signal used for anti-
sense transcription termination. The 2.4 kb length of the
presumed 3'UTR suggest that this region of the transcript
might play a role in the stability of the transcript, although
it still remains to be determined if splicing events might
be occurring at this 3' end. By Northern blot analysis, we
have not been able to detect the expected 4.1 kb size of the
antisense transcript in HIV-1-infected cell lines or 293T
cells transfected with proviral DNA. This is likely reminis-
cent of low levels of the antisense transcript, which is well
illustrated in our infection experiments conducted with
NL4.3LucR-E- and NL4.3AsLucR-E virions. Indeed, levels
of antisense transcript in these experiments are 30 to 1000
folds lower than that of sense transcripts. However, based
on our 5' and 3' analyses, the Northern blot signals ini-
tially attributed to antisense transcription presented by
Bukrinsky and Etkin (1990) [17] do not correspond to the
expected size and furthermore these results had not subse-
quently been confirmed by other groups.
An important contribution from our present study is the
generation of our pNL4.3AsLucR-E- construct. By transfec-
tion experiments, we have indeed demonstrated that luci-
ferase activity was being detected and that this vector
permitted the production of infectious pseudotyped viri-
ons, which produced a luciferase signal for at least three
days. The construct also allowed us to confirm previous
results from others in that T-cell activators could upregu-
late antisense transcription in both transfection and infec-
tion experiments. As opposed to these studies, we have
not seen any positive effect of TNFα on luciferase activity,
although other T-cell lines will need to be tested.
Although this might argue that NF-κB might not be
important for induction of antisense transcription, other
activators known to activate this transcription factors were
capable of upregulating levels of luciferase activity. Trans-
fection experiments with 3'LTR-deleted versions will be
required to pinpoint the transcription factors important
for this transcriptional modulation.
Our results have also surprisingly demonstrated that Tat
could upregulate antisense transcription. We have multi-
ple evidences favouring this conclusion: transient and sta-
ble transfection experiments indeed have been conducted
and luciferase reporter measurement and RT-PCR analyses
all lend credence to a positive modulation by Tat. Previ-
ous studies had rather suggested a negative role but as
stated in one of these studies [4,19,21], these results
might be consequential of TAR-dependent sense tran-
scription being strongly induced by Tat and having an
interference effect on luciferase transcript initiated from
the inverted 3'LTR. We have indeed demonstrated that
this was likely the case by linearizing the vector. Similar
conclusions were suggested by Bentley et al. who have
mutated the 3'LTR TATA box and then observed a low but
significant induction of antisense transcription by Tat. The
mechanism by which Tat could activate the antisense pro-
moter is unknown. Tat activates the expression of several
different cellular genes through different mechanisms
including binding to DNA-bound transcription factors
[26]. Although current model on the action of Tat through
TAR binding on sense transcription favours an increase in
the processivity of the RNA polII in sense transcription, it
is still possible that Tat could also act upon formation of
preinitiation complexes (PIC), as it has been recently
readdressed [27,28]. Indeed, several reports have indi-
cated that Tat can interact with factors present in the
preinitiation complex. However it should also be kept in
mind that Tat has been shown to modulate Sp1 binding
[29,30]. An important Sp1 site has previously been pro-
posed for antisense transcription [19] and could be the
target of Tat-mediated upregulation of antisense transcrip-
tion. More experiments will be required to determine the
mechanism by which Tat activates antisense transcription.
However, we are aware that the present effect of Tat on
antisense transcription was demonstrated in 5' LTR-
deleted proviral DNA constructs and thus this Tat-
dependent modulation of antisense transcription remains
to be confirmed in the context of a full-length proviral
DNA (for example, using a Tat-deficient proviral clone).
Infection experiments with NL4.3 based virions express-
ing an antisense reporter gene have revealed that this tool
could indeed be used to study antisense transcription in
the context of infection. The specificity of the luciferase
signal was confirmed by the addition of AZT. Interest-
ingly, the extent of luciferase activity was lower in tested T
and monocytic cells than in 293T cells for both sense and
antisense transcription. Remarkably, as pointed out
above, the results from our infection experiments with the
two different luciferase-encoding virions revealed that
antisense transcription was importantly lower than sense
transcription. A similar situation also exists for antisense
transcription in HTLV-I [2,12]. This low abundance might
be essential to avoid potential adverse effect of antisensePage 12 of 16
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tion. It is likely that sense transcription, especially upon
induction by Tat or T-cell stimulating agents contribute
importantly in keeping antisense RNA at low levels. It
might be postulated that sense transcription initiated
from the 3' LTR could also compete with limited amount
of transcription factors and also diminish the extent of
PIC formation on the antisense strand. In this regard, part
of the function of the antisense RNA might be viewed as a
true regulator of viral replication by acting as an antisense
as previously suggested [31]. As another possibility, the
antisense transcript might have a totally different role on
HIV-1 replication as recently suggested for the HTLV-I
antisense transcript [13].
Another possible function of this transcript is through its
encoding potential for the ASP protein. Important infor-
mation is still lacking and most importantly its detection
remains an important issue to solve. The nucleotidic
region of this ORF is well conserved and its presumed ATG
initiation is also very well preserved. HIV-1 is very heter-
ogenous in the sequence of its different strains, and one
might thus argue that the conservation of this ORF is an
indication of its encoding capacity. In addition, its posi-
tion is extremely similar to the HBZ ORF in HTLV-I. Pre-
liminary data from our group has suggested that
interrupting its translation by adding an in frame stop
codon importantly reduces extracellular p24 levels in
transfected cells, confirming previous data from Vaquero's
team [16]. We are currently conducting several experi-
ments to address issues related to this potential viral pro-
tein.
In conclusion, we have provided strong evidence for the
existence of antisense transcription in HIV-1 and our data
support a positive modulation of this transcript by the
viral Tat protein. We have produced an important tool,
which will permit to easily assess antisense transcription
following infection or transfection in the context of the
proviral DNA and in the chromatin environment. These
data are important as they represent an important aspect
of HIV-1 replication, which has been left unanswered. In
addition, the potentially encoded ASP protein needs to be
further studied. Understanding the function of this pro-
tein would add to the comprehension of HIV-1 pathogen-
esis. In addition, its suggested membrane-bound
localisation would make it a target for anti-retroviral treat-
ment and vaccine strategies.
Methods
Cell lines
T-cell line used in this study included Jurkat E6.1 [32],
SupT1[33] and CEMT4 [34]. Tested HIV-1 infected T-cell
lines were the ACH-2 [35] and J1.1 cell lines [36]. The
monocytic U937 [37], OM10.1 [38] and U937HIV-1IIIB
cell lines were also used in the present study, the two latter
being infected by two different HIV-1 strains. All these cell
lines were maintained in RPMI-1640 medium supple-
mented with 10% Fetal Bovine Serum (Hyclone Laborato-
ries, Logan, UT), 2 mM glutamine, 100 U/ml penicillin G,
and 100 µg/ml streptomycin. The human embryonic kid-
ney 293T fibroblast cell line [39] was grown in similarly
supplemented DMEM.
Plasmids and antibodies
The pCMV-tat vector was provided by Dr. O. Schwartz
(Unité d'Oncologie Virale, Institut Pasteur, Paris, France)
and contains the immediate early enhancer/promoter
region of the human cytomegalovirus placed upstream of
the viral tat gene [40]. The control vector pCMV5 was
kindly provided by Dr. É. Rassart (Université du Québec à
Montréal, Montreal Canada). The pAsLTRXLuc construct
was generated by excising the XhoI/HindIII 3'HIV-1 LAI
LTR fragment from pLTRXLuc and cloning this LTR frag-
ment after blunting in SmaI-digested pGL3-basic
(Promega, Naepean, Canada) in the inverse orientation
relative to the luciferase reporter gene. The pNL4.3 provi-
ral DNA clone is a full-length infectious HIV-1 molecular
clone provided by the NIH AIDS Research and Reference
Reagent Program (Rockville, MD). The pNL4.3LucR-E-
vector (containing the luciferase reporter gene and defi-
cient for envelope synthesis) was generously provided by
Dr. N. R. Landau (The Salk Institute for Biological Studies,
La Jolla, CA) [41]. The pNL4.3∆NarI construct was derived
from pNL4.3 by enzymatic digestion with NarI and self-
ligation, thereby deleting the 5' LTR sequence. The
pNL4.3AsLucR-E- vector was constructed by cloning the
XbaI (blunted)/XhoI luciferase fragment from pGL3-basic
in the NotI (blunted)/XhoI digested pNL4.3LucR-E- vec-
tor after excision of the luciferase reporter gene from this
vector. The 5'LTR-deleted pNL4.3∆BstAsLucR-E- construct
was derived from the pNL4.3AsLucR-E- vector by enzy-
matic digestion with BstZ17I and subsequent self ligation.
The pHCMV-G vector expressing the broad host-range
Vesicular Stomatitis Virus envelope glycoprotein G (VSV-
G) has been described previously [42]. The pActin-LacZ
vector contains the lacZ gene under the regulation of the
actin promoter. The hybridomas producing anti-p24
(clone 31-90-25 and 183H12-5C) antibodies were
obtained from the American Type Culture Collection
(Manassas VA). Antibodies from these hybridomas were
purified with mAbTrap protein G affinity columns accord-
ing to the manufacturer's instructions (Amersham Bio-
sciences Inc., Uppsala, Sweden).
Transient and stable transfections
293T cells were transfected in 24-well plates with Lipo-
fectamine 2000 (Invitrogen; Burlington, Canada) accord-
ing to manufacturer's suggestions. Transfected cells were
lysed 48 h. post-transfection in a lysis buffer (25 mM TrisPage 13 of 16
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glycerol) and luciferase activity was measured with the
Dynex MLX microplate luminometer (MLX Dynex Tech-
nologies, Chantilly, VA) with a single injection of a luci-
ferase buffer (20 mM tricine, 1.07 mM
(MgCO3)4·Mg(OH)2·5H2O, 2.67 mM MgSO4, 0.1 mM
EDTA, 220 µM Coenzyme A, 4.7 µM D-Luciferin potas-
sium salt, 530 µM ATP, 33.3 mM DTT). Each sample was
co-transfected with the β-gal-expressing vector for normal-
isation. The β-galactosidase activity was measured using
the Galacto-Light™ kit (Applied Biosystems, Bedford, MS)
according to manufacturer's suggestions. Luciferase activ-
ity is presented in Relative Light Units (RLU) and repre-
sents the calculated mean ± SD of three transfected
samples normalized by the measured β-galactosidase
activity. Jurkat cells were transfected by electroporation
with 15 µg of DNA using the Gene Pulser Xcell system
(Bio-Rad, Hercules CA) (960 µF, 250 V). Cells were resus-
pended at 37.5 × 106/ml of complete medium, transfected
in bulk and were separated at 16 h post-transfection into
various treatments group at a density of 1 × 105 cells/well
(100 µl) in 96-well flat-bottom plates. Cells were either
left untreated or were treated with phorbol 12-myristate
13-acetate (PMA) at 20 ng/mL (Sigma-Aldrich, Oakville,
Canada), phytohemagglutinin (PHA-P, Sigma-Aldrich,
Oakville, Canada) at 3 µg/mL, ionomycin (Sigma-Aldrich,
Oakville, Canada) at 1 µM, bpV [pic] (Alexis corp.) at 15
µM, forskolin (Sigma-Aldrich, Oakville, Canada) at 10
µM and TNFα at 20 ng/ml. Luciferase activity was moni-
tored as described above at 8 h. post-stimulation. Stable
transfection of 293T cells were performed as follow. Line-
arized pNL4.3∆BstAsLuc and pNL4.3∆NarI constructs
(upon digestion with BstZ17I and ApaI, respectively) were
co-transfected with each linearized plasmid with the
pCMV-Hyg vector in the presence of Lipofectamine 2000
according to manufacturer's instructions. After transfec-
tion (48 hours), Hygromycin B (Sigma-Aldrich, Oakville,
Canada) was added to the cells at a concentration of 200
µg/ml. Hygromycin-resistant clones were isolated and
tested for luciferase activity.
RT-PCR and 5'/3' RACE analyses
Total RNA was extracted by the Trizol reagent (Invitrogen;
Burlington, Canada). PolyA+ RNA was purified from
lysed cell samples using the Poly(A)Purist™ Kit (Ambion,
Austin TX) and according to manufacturer's instructions.
RT-PCR analyses were conducted using the EndoFree RT
Kit (Ambion, Austin TX) with RT primer 24-6 (5'-
TAAAACAAATTATAAACATGTGGC-3') or the RT primer
24-6F (5'-ATCATGAAGCATCTAGATTCAAAGTGCT-
GCTAAAACAAATTATAAACATGTGGC-3') (the non-com-
plementary sequence being indicated in bold) according
to manufacturer's instructions. Briefly, polyA+ RNA (250
ng) or total RNA (10 µg) were mixed with 1 µl of 10 µM
of a specific RT primer. The RNA:RT primer mix was
heated at 70°C for 5 min., equilibrated at 50°C for 5 min.
and incubated in the presence of the reaction mix contain-
ing 1× RT buffer, 1 µl of 2.5 mM dNTPs, 10 U of SuperAsin
RNAse inhibitor (Ambion) and 1 µl RT. For certain RT
reactions, cDNAs were purified through a QIAquick PCR
purification kit (Qiagen) before PCR amplification. Syn-
thesized cDNA were then PCR amplified in the presence
of 1.25 U Taq DNA polymerase, 1× ThermoPol buffer, 20
µM dNTPs, 1.5 µM of each primer using a Tgradient ther-
mocycler (Biometra, Goettingen, Germany). Primers
added to the PCR reactions were the reverse primer 26-6
(5'-AAAGCAATGTATGCCCCTCCCATCAG-3') and for-
ward primers 26-5 (5'-TGCTGTTGCGCCTCAATAGCCCT-
CAG-3'), 25-3 (5'-ATGCCCCAGACTGTGAGTTGCAACA-
3'), or the anchor primer 30-20 (5'-ATCATGAAGCATCTA-
GATTCAAAGTGCTGC-3') (specifically used for the RT
reactions performed in the presence of the 24-6F primer).
PCR conditions were as follow: a first step of denaturation
at 94°C for 5 min followed by 35 cycles of denaturation
(94°C for 1 min.), annealing (60°C for 1 min.) and exten-
sion (72°C for 1 min.) and a final extension at 72°C for
5 min. RT-PCR amplifications were controlled for DNA
contamination (RNA samples with no RT step), for the
presence of the RT floating primer (24-6F) after cDNA
purification (mixing a 24-6-synthesized cDNA with an RT
reaction performed with a 24-6F floating primer in non-
transfected 293T RNA) and endogenous RT priming
(cDNA synthesis reaction in the presence of RT with no
added specific primer). Extremities of the antisense tran-
script (5' and 3') were analyzed from isolated total RNA
with the FirstChoice RLM-RACE kit from Ambion accord-
ing to the manufacturer's instructions. For the 5'RACE
protocol, RNA was ligated to a supplied anchor at their 5'
end and cDNAs were subsequently synthesized with ran-
dom decamers. Two PCR rounds were conducted with the
supplied 5'RACE outer and inner primers and HIV-1-spe-
cific primers R1 (5'-AATCACAAGTAGCAATACAG-
CAGCTAA-3') and R2
(5'-CAATTATTGTCTGATATAGTGCAGCAGCAGAAC-3')
successively. For the 3'RACE protocol, cDNA synthesis
was performed in the presence of the supplied 3'RACE
adapter. PCR amplification was achieved through 3'RACE
inner and outer primers and HIV-1-specific forward
primer 30-10 (5'-GGCTGGGTTCGGTATTAAGGAA-3').
Amplified products were then cloned in pBlue Script KS+
(Stratagene, La Jolla CA) and sequenced.
Production of virus stocks
Virus particles were produced by calcium phosphate trans-
fection of virus-encoding vectors in 293T cells as previ-
ously described [43,44]. Briefly, 293T cells were plated 16
h. before transfection to reach a 50–80% confluence at the
day of transfection and then transfected with 35–40 µg
through the calcium phosphate protocol as previously
described [44]. Pseudotyped HIV-1 particles were gener-Page 14 of 16
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VSV-G envelope expression vector (5 µg of pHCMV-G).
Sixteen hours after transfection, cells were washed twice
with PBS and incubated for 24 h. in complete DMEM cul-
ture medium. Viruses were collected at this point by filter-
ing the culture media through a 0.22 µm pore size
cellulose acetate membrane. Virus stocks were normalized
for virion content using an in-house sensitive double anti-
body sandwich enzyme-linked immunosorbent assay
(ELISA) specific for the major core viral p24 protein as
previously described [44]. Virus stocks were aliquoted and
frozen at -80°C for future use. All virus stocks underwent
a single freeze-thaw cycle before use in infection studies.
Infections
293T cells were plated at 7.5 × 104 cells/well in 24-well
plates at 16 h before infection. Pseudotyped virions (37.5
ng p24) were added to each well and cells were lysed at
different time points post-infection with 200 µl of 1× lysis
buffer. Jurkat, U937, CEMT4 and SupT1 cells were seeded
in the presence of virions (1 ng of p24/10000 cells) in
complete medium at 1 × 106 cells/ml and incubated for 5
h. at 37°C. Cells were then resuspended at 1 × 106 cells/
ml in fresh medium and lysed at 48 h. post-infection.
Luciferase activity was monitored from 25 µl aliquot of
each cell lysate with the Dynex MLX microplate luminom-
eter (MLX Dynex Technologies, Chantilly, VA) upon addi-
tion of 100 µl of luciferase buffer as described above.
Mean luciferase activity ± standard deviation (SD) was cal-
culated using luciferase activities from three independent
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